Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses

Forensic Science International

Volumn 170, Issue 2-3, 2007, Pages 94-99

  Beránková, Kateřina ^a   Szkutová, Miroslava ^a   Balíková, Marie ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

2,5 Dimethoxy 4 bromoamphetamine; Disposition in rats; DOB; Metabolites; Toxicological analysis

Indexed keywords

2 METHOXY 5 HYDROXY 4 BROMOAMPHETAMINE; AMPHETAMINE DERIVATIVE; BROLAMFETAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; GAS CHROMATOGRAPHY; INGESTION; LIQUID LIQUID EXTRACTION; LUNG PARENCHYMA; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 34447627150     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2007.03.023     Document Type: Article

References (18)

1. Shulgin A., and Shulgin A. PIHKAL, A Chemical Love Story (1998), Transform Press, Berkeley, CA
2. deBoer D., and Bosman I. A new trend in drugs of abuse; the 2C-series of phenethylamine designer drugs. Pharm. World. Sci. 26 (2004) 110-113
3. Pedersen W., and Skrondal A. Ecstasy and new patterns of drug use: a normal population study. Addiction 94 (1999) 1695-1706
4. Acuna-Castillo C., Villalobos C., Moya P.R., Saez P., Cassels B.K., and Huidobro-Toro J.P. Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT2A and 5-HT2C receptors. Br. J. Pharmacol. 136 (2002) 510-519
5. Glennon R.A., Raghupathi R., Bartyzel P., Teitler M., and Leonhardt S. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. J. Med. Chem. 35 (1992) 734-740
6. Monte A.P., Marona-Lewicka D., Parker M.A., Wainscott D.B., Nelson D.L., and Nichols D.E. Dibenzofuran analogues of hallucinogens. Three models of 4-substituted (2,5-dimethoxyphenyl) alkylamine derivatives with rigidified methoxy groups. J. Med. Chem. 39 (1996) 2953-2961
7. Spinella M. Psychopharmacology of Herbal Medicine (2001), The MIT Press, Cambridge
8. Shulgin A.T., Sargent T., and Naranjo C. 4-Bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog. Pharmacology 5 (1971) 103-107
9. Toennes S.W., Ohlmeier M., Schmidt K., and Kauert G. Aufklärung eines unklaren neurologischen Syndroms durch toxikologische Untersuchungen. Deut. Med. Wochenschr. 125/30 (2000) 900-902
10. Delliou D. 4-Bromo-2,5-dimethoxyamphetamine: psychoactivity, toxic effects and analytical methods. Forensic Sci. Int. 21 (1983) 259-267
11. Balíková M. Nonfatal and fatal DOB (2,5-dimethoxy-4-bromamphetamine) overdose. Forensic Sci. Int. 153 (2005) 85-91
12. Furnari C., Ottaviano V., and Rosati F. Determination of 4-bromo-2,5-dimethoxyamphetamine (DOB) found in illicit tablets seized in Italy. Ann. Ist. Super. Sanita 37 (2001) 297-300
13. Marvin Davis W. LSD or DOB?. Am. J. Psychiat. 139 (1982) 1649-1651
14. Sargent T., Kalbhen D.A., and Shulgin A.T. In vivo human pharmacodynamics of the psychodysleptic 4-Br-2,5-dimethoxyphenylisopropylamine labelled with 82Br or 77Br. Neuropharmacology 14 (1975) 165-174
15. Scheline R.R. Mammalian Metabolism of Plant Xenobiotics (1978), Academic Press, London
16. Beránková K., and Balíková M. Study on metabolites of 2,5-dimethoxy-4-bromamphetamine (DOB) in human urine using gas chromatography-mass spectrometry. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149/2 (2005) 465-468
17. Ewald A.H., Fritschi G., Bork W.R., and Maurer H.H. Designer drugs, 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic-mass spectrometric techniques. J. Mass Spectrom. 41 (2006) 487-496
18. Kanamori T., Inoue H., Iwata Y., Ohmae Y., and Kishi T. In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites. J. Anal. Toxicol. 26 (2002) 61-66